Clinical Trials Logo

Metabolic Syndrome clinical trials

View clinical trials related to Metabolic Syndrome.

Filter by:

NCT ID: NCT00448630 Completed - Schizophrenia Clinical Trials

An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics

MESSAGE
Start date: October 23, 2007
Phase:
Study type: Observational

The purpose of the study is to find and follow-up the metabolic syndrome parameters on patients administering atypical antipsychotics.

NCT ID: NCT00444717 Completed - Metabolic Syndrome Clinical Trials

Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome

Start date: April 2007
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate anti-oxidative and anti-inflammatory effects of pitavastatin in hypercholesterolemic patients with the metabolic syndrome.

NCT ID: NCT00443755 Completed - Type 2 Diabetes Clinical Trials

Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance

Start date: August 2005
Phase: Phase 2
Study type: Interventional

The objective of this study is to determine whether targeted pharmacological improvement of insulin sensitivity will normalize the associated elevations of thrombotic and inflammatory cardiovascular disease (CVD) biomarkers in individuals with insulin resistance.

NCT ID: NCT00442689 Completed - Metabolic Syndrome Clinical Trials

Metabolic Syndrome in PCOS: Precursors and Interventions

Start date: July 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the metabolic effects of anti-androgens and oral contraceptive pills (OCPs), compared with placebo, in the treatment of women with PCOS. We hypothesized that controlling elevated androgen levels with either anti-androgens or OCPs would produce improvement in metabolic markers in PCOS women and would reduce their long term metabolic risk.

NCT ID: NCT00438321 Terminated - Metabolic Syndrome Clinical Trials

Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome

Start date: September 2006
Phase: Phase 1
Study type: Interventional

The purpose of the study is to examine the effect of testosterone treatment on insulin in men with the metabolic syndrome with testosterone levels at or below the lower end of the normal range.

NCT ID: NCT00438126 Completed - Obesity Clinical Trials

Family-Centered Diabetes Project - Sharing Wisdom

Start date: January 2002
Phase: N/A
Study type: Interventional

This is a randomized trial of an educational intervention to reduce the risk of diabetes among urban American Indian women

NCT ID: NCT00436475 Completed - Clinical trials for Type 2 Diabetes Mellitus

Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes

CaDDM
Start date: September 2007
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the randomized trial is to quantify the effect of vitamin D and calcium supplementation on beta-cell function, insulin sensitivity, glucose tolerance and systemic inflammation and other cardiometabolic outcomes in ambulatory adults at high risk for type 2 diabetes.

NCT ID: NCT00433173 Suspended - Metabolic Syndrome Clinical Trials

Insulin Sensitivity in Men With the Metabolic Syndrome

Start date: May 2006
Phase: N/A
Study type: Interventional

The metabolic syndrome is a medical condition defined by high levels of cholesterol in the blood, high blood pressure, central obesity (gain in fat around the region of the stomach), and insulin resistance (body responds less well to insulin). This state of impaired insulin resistance can lead to type 2 diabetes mellitus, which is one of the most common metabolic disorders in the U.S. Numerous studies have shown an inverse relationship between insulin resistance and testosterone levels in men, however, causality has not been established. This protocol investigates the role of testosterone in modulating insulin sensitivity in insulin resistant states such as the metabolic syndrome. The hypothesis is that testosterone administration will improve insulin sensitivity.

NCT ID: NCT00433082 Completed - Metabolic Syndrome Clinical Trials

Metabolic Syndrome and Inflammatory Markers

Start date: August 2006
Phase: N/A
Study type: Interventional

The metabolic syndrome has been recognized as a proinflammatory state. It has been shown that many different diets such as Mediterranean diet, DASH diet, Foods with low glycemic index and low saturated fat diet, independent of weight loss, may be effective in improving the metabolic syndrome. Our objective was to evaluate the effect of Ramadan fasting on High-sensitive C-reactive protein (hs-CRP) and fibrinogen levels in metabolic syndrome.

NCT ID: NCT00432952 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Acute Single Meal Effects of Trout on Cardiovascular Risk Markers and Plasma Proteome

Start date: January 2007
Phase: N/A
Study type: Interventional

The acute effects of farmed rainbow trout, fed by various feeds versus a control meal with poultry meat on cardiovascular risk markers and plasma protein expression are investigated. The hypotheses of the study are that if the feed are changed from a marine origin to primarily a vegetable origin the content of long chain n-3 poly unsaturated fatty acids (n-3 PUFA) will decrease in the meat and thus possibly result in a decreased effect on health. Furthermore, the feed of the trouts are also expected to give rise to differences in the human plasma protein profile and fatty acid composition after consumption, which could be associated with physiological effects.